(CDXS:Consolidated Issue Listed on NASDAQ Global Select )
Gerhard N. Mayr
Special Advisor to the Board, Codexis, Inc.
|Age||Total Calculated Compensation||This person is connected to 44 board members in 6 different organizations across 12 different industries.|
See Board Relationships
Dr. Gerhard N. Mayr has been a Special Advisor of Board of Codexis, Inc., since July 2004. Dr. Mayr serves as the Head of Stability Control - Goa at Ratiopharm India Private Limited. Prof. Dr. Mayr served as an Executive Vice President of Pharmaceutical Operations at Eli Lilly & Co. from October 1999 to March 1, 2004 and was responsible for pharmaceutical operations worldwide and sales and marketing globally. Prof. Dr. Mayr joined Eli Lilly International Corporation, ...
200 Penobscot DrivePhone: 650-421-8100
Redwood City, California 94063
Board Members Memberships*
Special Advisor to the Board
Chairman and Member of Audit Committee
Former Director and Member of Audit & Compliance Committee
Former Director, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Audit Committee
Independent External Director and Member of Audit Committee
Master's Degree 1969
Eidgenössische Technische Hochschule Zürich
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Steven M. Klosk||Chief Executive Officer, President and Director|
|Feike Sijbesma||Chairman of the Managing Board and Chief Executive Officer|
Koninklijke DSM N.V.
|Satoshi Masumura||Chief Executive Officer, President, General Manager of Corporate R&D Division & EHS Headquarters and Representative Director|
Takasago International Corporation
|Peder Holk Nielsen||Chief Executive Officer and President|
|kr9.7M||Compensation as of Fiscal Year 2014.|